STOCK TITAN

[SCHEDULE 13G/A] Adaptive Biotechnologies Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Rubric Capital Management LP
Signature:/s/ Michael Nachmani
Name/Title:Michael Nachmani / Chief Operating Officer
Date:07/09/2025
David Rosen
Signature:/s/ David Rosen
Name/Title:David Rosen, Individually
Date:07/09/2025
Adaptive Biotechnologies

NASDAQ:ADPT

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.01B
148.13M
2.34%
97.62%
6.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SEATTLE